|
|
Article: Celecoxib in preventing skin cancer in patients with actinic keratoses.(Clinical Trial Review)
- Article from:
- Journal of Drugs in Dermatology
- Article date:
- May 1, 2004
CopyrightCOPYRIGHT 2004 Journal of Drugs in Dermatology, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
This study is currently recruiting patients.
Sponsored by UAB Comprehensive Cancer Center, National Cancer Institute (NCI)
Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of celecoxib may be an effective way to prevent actinic keratoses. This is a randomized Phase II/III trial to determine the effectiveness of celecoxib in preventing skin cancer in patients who ...